PUBLISHER: IMARC | PRODUCT CODE: 1722422
PUBLISHER: IMARC | PRODUCT CODE: 1722422
The global shoulder arthroplasty market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is propelled by the increasing incidence of shoulder arthritis, development of better implant materials, expanding indications for shoulder replacement procedures, rising population of geriatrics, and heightened consciousness of invasive surgeries.
Shoulder arthroplasty is a surgical procedure wherein diseases or damaged ball and socket joints of the shoulder are replaced with a prosthesis made of metal components or plastic implants. It is generally performed after a thorough evaluation of patients using x-rays, blood tests, bone scans, physical examinations, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans. Presently, it is used to treat individuals with primary osteoarthritis, post-traumatic arthritis, inflammatory arthritis, proximal humeral fractures, osteonecrosis of the humeral head and neck, and pseudo paresis caused by rotator cuff deficiency.
Several conditions, such as inflammatory arthritis, osteonecrosis involving the glenoid and post-traumatic degenerative joint disease, can cause shoulder pain and disability and interfere with the everyday activities of patients. Thus, a significant rise in the number of individuals suffering from these conditions represents one of the key factors augmenting the need for shoulder arthroplasty. Moreover, as shoulder pain increases with age, the growing aging population is catalyzing the adoption of shoulder arthroplasty to preserve their shoulder joint mobility and function. Apart from this, high-force and repetition activities required by athletics during performance can result in severe shoulder fracture or damage. This, in confluence with the increasing participation of individuals in professional sports, is influencing the market positively. Furthermore, market players are offering an extensive array of implants for shoulder reconstruction in different conditions. They are also introducing modern implants with a wide range of options, including resurfacing the humeral head, anatomic hemiarthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, and trauma-specific implants for fractures and nonunions. This is anticipated to expand their overall share and drive the market in the coming years.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation and Zimmer Biomet.